SCHEMBL25501955

SCHEMBL25501955

O=S(=O)(Nc1ccccc1)N1CCOC(C(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
HSD17B10 Q99714 2/20 0.37
ADRB3 P13945 2/20 0.34
FKBP1A P62942 3/20 0.34
KMT2A Q03164 3/20 0.34
GLA P06280 1/20 0.34
SLC6A3 Q01959 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25501797 0.92 KMT2A (0.44) POLBCHRNB4CHRNA3HSD17B10FKBP1A
SCHEMBL25502166 0.86 FKBP1A (0.42) POLBFKBP1AKMT2AGLAMAPT
SCHEMBL23848610 0.85 KMT2A (0.50) POLBFKBP1AKMT2AGLAMEN1
SCHEMBL23848206 0.82 KMT2A (0.41) FKBP1AKMT2AGLAMEN1
SCHEMBL23848476 0.80 KMT2A (0.45) POLBHSD17B10FKBP1AKMT2AGLA
SCHEMBL23832805 0.80 KMT2A (0.45) POLBFKBP1AKMT2AGLAMEN1
SCHEMBL23832785 0.80 KMT2A (0.42) POLBFKBP1AKMT2AGLAMEN1
SCHEMBL25502088 0.79 KMT2A (0.40) FKBP1AKMT2AGLAMEN1MAPT
SCHEMBL25502161 0.79 FKBP1A (0.42) POLBFKBP1AKMT2AGLASMN1; SMN2
SCHEMBL23832787 0.79 FKBP1A (0.43) POLBFKBP1AKMT2AGLAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF ATUX ISKAY LLC 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146127-A1 3-DIARYLMETHYLENES AND USES THEREOF MYC, MYCBP, FOXO1 POLB 1988/4885CHRNB4 4202/4885CHRNA3 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.